华北制药: 2025年半年度业绩预增公告

Group 1 - The company expects to achieve a net profit of approximately 123.5 million yuan for the first half of 2025, representing an increase of about 65.05 million yuan or approximately 120% compared to the same period last year [1] - The net profit for the first half of 2025 is projected to be around 119.4 million yuan, which is an increase of about 65.05 million yuan or approximately 120% year-on-year [1] - The company reported a total profit of 150.0084 million yuan and a net profit attributable to the parent company of 12.35 million yuan in the same period last year [1] Group 2 - The increase in profit is attributed to the company's implementation of comprehensive budget management, lean management practices, and cost reduction measures, which have improved profitability [1]